ºÝºÝߣshows by User: driceman / http://www.slideshare.net/images/logo.gif ºÝºÝߣshows by User: driceman / Sat, 04 Jun 2011 17:37:00 GMT ºÝºÝߣShare feed for ºÝºÝߣshows by User: driceman Ims Perfecting Market Access In Apac /slideshow/ims-perfecting-market-access-in-apac/8209618 imsperfectingmarketaccessinapac-13072270088173-phpapp02-110604175537-phpapp02
]]>
]]> Sat, 04 Jun 2011 17:37:00 GMT /slideshow/ims-perfecting-market-access-in-apac/8209618 driceman@slideshare.net(driceman) Ims Perfecting Market Access In Apac driceman <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/imsperfectingmarketaccessinapac-13072270088173-phpapp02-110604175537-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Ims Perfecting Market Access In Apac from George J Syrmalis
]]> 981 6 https://cdn.slidesharecdn.com/ss_thumbnails/imsperfectingmarketaccessinapac-13072270088173-phpapp02-110604175537-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Biosimilars report /slideshow/biosimilarsreport/7988374 biosimilarsreport-13055955264281-phpapp01-110516202834-phpapp01
This is a great biosimilar report that we would like to share with our colleagues]]>
This is a great biosimilar report that we would like to share with our colleagues]]> Mon, 16 May 2011 20:26:27 GMT /slideshow/biosimilarsreport/7988374 driceman@slideshare.net(driceman) Biosimilars report driceman This is a great biosimilar report that we would like to share with our colleagues <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/biosimilarsreport-13055955264281-phpapp01-110516202834-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> This is a great biosimilar report that we would like to share with our colleagues
Biosimilars report from George J Syrmalis
]]> 7269 16 https://cdn.slidesharecdn.com/ss_thumbnails/biosimilarsreport-13055955264281-phpapp01-110516202834-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 KOL MANAGEMENT /slideshow/kol-management/7823637 kolexpertsjan2009-13044608506574-phpapp02
A great presentation on KOL management]]>
A great presentation on KOL management]]> Tue, 03 May 2011 17:14:56 GMT /slideshow/kol-management/7823637 driceman@slideshare.net(driceman) KOL MANAGEMENT driceman A great presentation on KOL management <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/kolexpertsjan2009-13044608506574-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> A great presentation on KOL management
KOL MANAGEMENT from George J Syrmalis
]]> 19254 30 https://cdn.slidesharecdn.com/ss_thumbnails/kolexpertsjan2009-13044608506574-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Art And Science Of Biotech Valuations Gs Final /slideshow/art-and-science-of-biotech-valuations-gs-final-7667774/7667774 artandscienceofbiotechvaluationsgsfinal-1303161051444-phpapp01
Art &amp; Science of Biotech Investment]]>
Art &amp; Science of Biotech Investment]]> Mon, 18 Apr 2011 16:11:26 GMT /slideshow/art-and-science-of-biotech-valuations-gs-final-7667774/7667774 driceman@slideshare.net(driceman) Art And Science Of Biotech Valuations Gs Final driceman Art &amp; Science of Biotech Investment <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/artandscienceofbiotechvaluationsgsfinal-1303161051444-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Art &amp;amp; Science of Biotech Investment
Art And Science Of Biotech Valuations Gs Final from George J Syrmalis
]]> 2431 22 https://cdn.slidesharecdn.com/ss_thumbnails/artandscienceofbiotechvaluationsgsfinal-1303161051444-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://cdn.slidesharecdn.com/profile-photo-driceman-48x48.jpg?cb=1604368237 • Innovative biotechnology strategist and successful life science entrepreneur trained in Nuclear Medicine-Radiation Immunology. • Founder of the iQ Group Global, Executive Chairman of iQnovate Ltd, Executive Director of iQX Limited, and CEO of iQ3Corp. Ltd., as well as Executive Member of the iQX Investment Services, Fund Investment Committee. • Founder and former CEO and Chairman of The Bionuclear Group SA (1995-2005). The core business activities of the Group were: oncology radiopharmaceutical R&D; Operation of renal dialysis clinics for End Stage Renal Disease patients; Management and ownership of Medical Centres and reference pathology laboratories; and the development of both th... http://www.iqnovate.com https://cdn.slidesharecdn.com/ss_thumbnails/imsperfectingmarketaccessinapac-13072270088173-phpapp02-110604175537-phpapp02-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/ims-perfecting-market-access-in-apac/8209618 Ims Perfecting Market ... https://cdn.slidesharecdn.com/ss_thumbnails/biosimilarsreport-13055955264281-phpapp01-110516202834-phpapp01-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/biosimilarsreport/7988374 Biosimilars report https://cdn.slidesharecdn.com/ss_thumbnails/kolexpertsjan2009-13044608506574-phpapp02-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/kol-management/7823637 KOL MANAGEMENT